Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Zimmer Biomet Holdings Inc ZBH

Zimmer Biomet Holdings, Inc. is a global medical technology company. Its segments include Americas, EMEA, and Asia Pacific. The Company designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; craniomaxillofacial and thoracic (CMFT) products; surgical products; and a suite of integrated digital and robotic technologies... see more

Bullboard (NYSE:ZBH)

View:
Post by whytestockson Feb 08, 2024 10:00pm

Zimmer Biomet Announces Fourth Quarter and Full-Year 2023 Fi

News; $ZBH Zimmer Biomet Announces Fourth Quarter and Full-Year 2023 Financial ResultsZimmer Biomet Announces Fourth Quarter and Full-Year 2023 Financial Results PR Newswire Fourth quarter net sales ...more  
Post by edwardebreen15on Aug 19, 2022 6:18am

Minimally Invasive Surgery Market Trends & Forecast 2022-27

According to IMARC Group’s latest report, titled “Minimally Invasive Surgery Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, the global market reached a value ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities